Dexamethasone-Loaded Lipid Calcium Phosphate Nanoparticles Treat Experimental Colitis by Regulating Macrophage Polarization in Inflammatory Sites
Kai Dong,Ying Zhang,Hong Rui Ji,Ze Lin Guan,Dan Yang Wang,Zi Yang Guo,Shu Jing Deng,Bin Yang He,Jian Feng Xing,Cui Yu You
DOI: https://doi.org/10.2147/ijn.s442369
IF: 7.033
2024-01-28
International Journal of Nanomedicine
Abstract:Kai Dong, 1, 2 Ying Zhang, 2 Hong Rui Ji, 2 Ze Lin Guan, 2 Dan Yang Wang, 2 Zi Yang Guo, 2 Shu Jing Deng, 2 Bin Yang He, 2 Jian Feng Xing, 2 Cui Yu You 1 1 Department of Pharmacy, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, People's Republic of China; 2 School of Pharmacy, Xi'an Jiaotong University, Xi'an, Shaanxi, People's Republic of China Correspondence: Jian Feng Xing, School of Pharmacy, Xi'an Jiaotong University, 76 Yanta West Road, Xi'an, Shaanxi, 710061, People's Republic of China, Tel +86-29-82655139, Fax +86-29-82655139, Email Cui Yu You, Department of Pharmacy, The First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta West Road, Xi'an, Shaanxi, 710061, People's Republic of China, Tel +86-29-85323241, Fax +86-29-85323240, Email Background: The M1/M2 polarization of intestinal macrophages exerts an essential function in the pathogenesis of ulcerative colitis (UC), which can be adjusted to alleviate the UC symptoms. Purpose: A kind of pH-sensitive lipid calcium phosphate core-shell nanoparticles (NPs), co-loading with dexamethasone (Dex) and its water-soluble salts, dexamethasone sodium phosphate (Dsp), was constructed to comprehensively regulate macrophages in different states towards the M2 phenotype to promote anti-inflammatory effects. Methods: Dex and Dsp were loaded in the outer lipid shell and inner lipid calcium phosphate (Cap) core of the L d CaP d NPs, respectively. Then, the morphology of NPs and methods for determining drug concentration were investigated, followed by in vitro protein adsorption, stability, and release tests. Cell experiments evaluated the cytotoxicity, cellular uptake, and macrophage polarization induction ability of NPs. The in vivo distribution and anti-inflammatory effect of NPs were evaluated through a 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced BALB/c mice ulcerative colitis model. Results: The L d CaP d NPs showed a particle size of about 200 nm and achieved considerable loading amounts of Dex and Dsp. The in vitro and in vivo studies revealed that in the acidic UC microenvironment, the cationic lipid shell of L d CaP d underwent protonated dissociation to release Dex first for creating a microenvironment conducive to M2 polarization. Then, the exposed CaP core was further engulfed by M1 macrophages to release Dsp to restrict the pro-inflammatory cytokines production by inhibiting the activation and function of the nuclear factor kappa-B (NF-κB) through activating the GC receptor and the NF kappa B inhibitor α (I-κBα), respectively, ultimately reversing the M1 polarization to promote the anti-inflammatory therapy. Conclusion: The L d CaP d NPs accomplished the sequential release of Dex and Dsp to the UC site and the inflammatory M1 macrophages at this site, promoting the regulation of macrophage polarization to accelerate the remission of UC symptoms. Keywords: ulcerative colitis, calcium phosphate, macrophage polarization, colon targeted delivery system, dexamethasone Graphical Ulcerative colitis (UC) is a chronic and non-specific inflammatory disease involved in the colon and rectum mucosa, characterized by local inflammatory cell infiltration and the aggregation of inflammatory mediators in the local intestine. 1 Numerous neutrophils, lymphocytes, and macrophages appear alternately during the development of UC, making the course of UC persistent and recurring, thus seriously affecting the health and quality of patients' life, and increasing the risk of UC-related cancers. 2–5 Currently, there is no cure for UC, and some patients need total colorectal resection. 6 Therefore, the treatment of UC has become a thorny clinical issue. The pathogenesis of UC is related to multiple factors, among which the macrophages at the intestine inflammatory site exert essential functions. 7,8 The phenotype and function of intestinal macrophages are constantly changing dynamically. 9,10 Various environmental stimuli trigger macrophage polarization in different directions to produce the classical pathway-activated macrophages (M1) and the alternative pathway-activated macrophages (M2). 11 Macrophages in intestinal tissues are usually activated and polarized into the M1 phenotype under the stimulation of abnormal intestinal antigens and inflammatory factors to accelerate intestinal mucosa damage. 12 The M1 macrophages secrete cytokines, chemokines, and adhesion factors (eg, TNF-α, IL-1β, and IL-12) that destroy the intestinal mucosal -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology